Ubigene Biosciences

We are located in Guangzhou Science City, Guangdong province, China, which serves as a global center for high technology and innovation. Make genome editing easier is the goal of Ubigene. We are committed to providing the best gene-editing services and products to every customer who chooses us. Innovatively improved from CRISPR/Cas9 technology, CRISPR-U™ has greatly improved the efficiency of gene cutting and homologous recombination, thus improving the gene-editing efficiency by 10-20 times. Ubigene had optimized the microbial gene-editing vectors and process. It is an automated gene-editing strategy design system. Combining with 3000 cases of gene-editing data, bioinformatics and information technology, Ubigene created this system to benefit researchers who work on gene editing. This platform is based on self-developed UBI-001 near-haploid cell line and 2000+ KO cell bank.